INTRALINE® SPIRAL S2938 – 29G 38mm/50mm

Product Description

The INTRALINE® SPIRAL S2938 is an advanced PDO thread technology. This spiral thread configuration utilizes a 29G needle system with dual length options of 38mm and 50mm, providing versatility for various treatment applications. The spiral design enhances tissue anchoring capabilities while promoting sustained collagen stimulation throughout the treatment area.

INTRALINE® SPIRAL S2938 Dosage and Administration

Treatment protocols require careful assessment of individual patient needs and treatment objectives. The recommended insertion technique involves placing the device into the subdermal tissue layers using aseptic procedures. Medical professionals should follow established thread-lifting protocols to achieve optimal therapeutic outcomes.

The spiral thread configuration requires specific handling techniques to maintain structural integrity during insertion. Treatment frequency depends on the individual patient’s response and desired aesthetic goals, with typical effects lasting 12-18 months. Practitioners should thoroughly evaluate treatment areas before determining the appropriate thread placement patterns.

Ingredient Information

The active component consists of polydioxanone (PDO), a biocompatible and biodegradable polymer extensively used in medical applications. This PDO material provides predictable absorption characteristics while maintaining structural integrity throughout the treatment period. The polymer composition supports natural tissue healing processes and promotes sustained collagen synthesis.

The spiral thread incorporates a single PDO filament twisted around the needle, creating enhanced surface area for tissue interaction. This design maximizes the therapeutic potential of the PDO material while ensuring consistent treatment delivery across various anatomical areas.

Storage Instructions

Proper storage maintains product integrity and ensures optimal performance characteristics. Store at room temperature between 2°C and 25°C, protecting from direct sunlight and moisture exposure. Maintain original packaging until use to preserve sterility and prevent contamination.

INTRALINE® SPIRAL S2938 Contraindications

Treatment contraindications include active skin infections at proposed treatment sites, known allergies to PDO material, and patients with autoimmune disorders. Individuals with coagulation disorders or bleeding tendencies require careful evaluation before treatment consideration.

Pregnant or nursing patients should avoid treatment with PDO threads. Patients with unrealistic expectations or psychological conditions affecting treatment compliance may not be suitable candidates. Areas with previous surgical procedures or existing implants require thorough assessment before treatment planning.

INTRALINE® SPIRAL S2938 Precautions and Warnings

Medical professionals must maintain strict aseptic techniques throughout the treatment process to prevent complications from infection. Proper needle insertion techniques prevent thread migration or unintended tissue damage. Patient education regarding post-treatment care is essential for optimal outcomes.

INTRALINE® SPIRAL S2938 Manufacturer and Regulatory Information

Manufactured by Mecobi Co. Ltd., the INTRALINE® SPIRAL S2938 meets stringent medical device regulations and quality standards. The product is certified with CE marking, demonstrating compliance with European safety and efficacy requirements.

Quality assurance protocols ensure consistent product performance and sterility throughout the manufacturing process. Regulatory oversight provides healthcare professionals with confidence in the safety and effectiveness of products. The manufacturer maintains comprehensive documentation supporting clinical applications and safety profiles for professional reference.